Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.

Hussein, O; Schlezinger, S; Rosenblat, M; Keidar, S; Aviram, M

Hussein, O; Schlezinger, S; Rosenblat, M; Keidar, S; Aviram, M.

Affiliation

Hussein O; Lipid Research Laboratory, Rambam Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Atherosclerosis ; 128(1): 11-8, 1997 Jan 03.

Article in En | MEDLINE | ID: mdl-9051193

Subject(s)

Anticholesteremic Agents/therapeutic use; Fatty Acids, Monounsaturated/therapeutic use; Indoles/therapeutic use; Lipid Peroxidation/drug effects; Lipids/blood; Lipoproteins, LDL/metabolism; Adult; Aged; Amidines/pharmacology; Anticholesteremic Agents/metabolism; Copper Sulfate/pharmacology; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated/metabolism; Fluvastatin; Free Radical Scavengers/metabolism; Humans; Hypercholesterolemia/blood; Hypercholesterolemia/drug therapy; Indoles/metabolism; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Fatty Acids, Monounsaturated / Lipid Peroxidation / Indoles / Lipids / Lipoproteins, LDL / Anticholesteremic Agents Type of study: Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Atherosclerosis Year: 1997 Document type: Article Affiliation country: Israel Country of publication: Ireland

Search on Google

Add to My VHL

XML

PubMed Links